CHRISTOPHER LIENDO: Open Payments
NPI 1467181362 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,375 in 180 payments from 18 companies in 2025. Trend: 2023 $2,880 · 2024 $2,584 · 2025 $3,375
Food & beverage: $3,294Education: $81
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $480 |
| ABBVIE INC. | 23 | $373 |
| LEO Pharma Inc. | 15 | $330 |
| UCB, Inc. | 18 | $327 |
| PFIZER INC. | 25 | $298 |
| Novartis Pharmaceuticals Corporation | 13 | $288 |
| GENZYME CORPORATION | 6 | $255 |
| Janssen Biotech, Inc. | 12 | $237 |
| Lilly USA, LLC | 13 | $202 |
| Galderma Laboratories, L.P. | 11 | $162 |
Products named: DUPIXENT, Bimzelx, CIBINQO, TREMFYA, TALTZ, COSENTYX, RINVOQ, SKYRIZI.
Industry payments across TX — which companies pay providers there.
